Female ROMK null mice manifest more severe Bartter II phenotype on renal function and higher PGE2 production

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 295, Issue 3, 2008, Pages

  Yan, Qingshang ^a   Yang, Xinbo ^a   Cantone, Alessandra ^a   Giebisch, Gerhard ^a   Hebert, Steven ^a   Wang, Tong ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gender difference; Hydronephrosis; Renal function; ROMK Bartter's

Indexed keywords

ELECTROLYTE; POTASSIUM; POTASSIUM CHANNEL; PROSTAGLANDIN E2; RENAL OUTER MEDULLARY POTASSIUM CHANNEL; SODIUM; THROMBOXANE B2; UNCLASSIFIED DRUG; INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BARTTER SYNDROME; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROLYTE BLOOD LEVEL; FEMALE; HYDRONEPHROSIS; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; SEX DIFFERENCE; SODIUM EXCRETION; SURVIVAL RATE; URINARY EXCRETION; WILD TYPE; AGE; ANIMAL; BODY WEIGHT; COMPARATIVE STUDY; GENETICS; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; METABOLISM; MORTALITY; MOUSE MUTANT; PATHOPHYSIOLOGY; SEXUAL DEVELOPMENT; URINE;

AGE FACTORS; ANIMALS; BARTTER SYNDROME; BODY WEIGHT; DINOPROSTONE; FEMALE; GLOMERULAR FILTRATION RATE; HYDRONEPHROSIS; MALE; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PHENOTYPE; POTASSIUM; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; SODIUM; SURVIVAL RATE; THROMBOXANE B2; URINE;

EID: 54049097894     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00051.2007     Document Type: Article

References (46)

1. Baiardi G, Macova M, Armando I, Ando H, Tyurmin D, Saavedra JM. Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul Pept 124: 7-17, 2005.
2. Bartter FC, Pronove P, Gill JR Jr, and Maccardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 33: 811-828, 1962.
3. Bonvalet JP, Pradelles P, Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol Renal Fluid Electrolyte Physiol 253: F377-F387, 1987.
4. Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Quan H, Gertz BJ, FitzGerald GA. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 289: 735-741, 1999.
5. Cheng HF, Wang JL, Zhang MZ, Miyazaki Y, Ichikawa I, McKanna JA, Harris RC. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest 103: 953-961, 1999.
6. Craig JC, Falk MC. Indomethacin for renal impairment in neonatal Bartter's syndrome. Lancet 347: 550, 1996.
7. Derst C, Wischmeyer E, Preisig-Muller R, Spauschus A, Konrad M, Hensen P, Jeck N, Seyberth HW, Daut J, Karschin A. A hyperprostaglandin E syndrome mutation in Kir1.1 (renal outer medullary potassium) channels reveals a crucial residue for channel function in Kir13 channels. J Biol Chem 273: 23884-23891, 1998.
8. Fujimura A, Ebihara A. Role of angiotensin II in renal prostaglandin E2 production after furosemide administration. Hypertension 11: 491-494, 1988.
9. Gill JR Jr. Bartter's syndrome. Annu Rev Med 31: 405-419, 1980.
10. Gregory MS, Duffner LA, Faunce DE, Kovacs EJ. Estrogen mediates the sex difference in post-burn immunosuppression. J Endocrinol 164: 129-138, 2000.
11. Gullner HG, Smith JB, Cerletti C, Gill JR Jr, and Bartter FC. Correction of increased prostacyclin synthesis in Bartter's syndrome by indomethacin treatment. Prostaglandins Med 4: 65-72, 1980.
12. Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 281: F1-F11, 2001.
13. Hebert SC. Bartter syndrome. Curr Opin Nephrol Hypertens 12: 527-532, 2003.
14. Hura CE, Kunau RT Jr. Angiotensin II-stimulated prostaglandin production by canine renal afferent arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 254: F734-F738, 1988.
15. Iino Y, Imai M. Effects of prostaglandins on Na transport in isolated collecting tubules. Pflügers Arch 373: 125-132, 1978.
16. +-ATPase activity in the inner medullary collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 257: F424-F430, 1989.
17. Jaimes EA, Tian RX, Pearse D, Raij L. Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int 68: 2143-2153, 2005.
18. Jeck N, Schlingmann KP, Reinalter SC, Komhoff M, Peters M, Waldegger S, Seyberth HW. Salt handling in the distal nephron: lessons learned from inherited human disorders. Am J Physiol Regul Integr Comp Physiol 288: R782-R795, 2005.
19. Kaji DM, Chase HS Jr, Eng JP, Diaz J. Prostaglandin E2 inhibits Na-K-2Cl cotransport in medullary thick ascending limb cells. Am J Physiol Cell Physiol 271: C354-C361, 1996.
20. Klotman PE, Smith SR, Volpp BD, Coffman TM, Yarger WE. Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 250: F282-F287, 1986.
21. Komhoff M, Wang JL, Cheng HF, Langenbach R, McKanna JA, Harris RC, Breyer MD. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 57: 414-422, 2000.
22. Kuhl PG, Schonig G, Schweer H, Seyberth HW. Increased renal biosynthesis of prostaglandin E2 and thromboxane B2 in human congenital obstructive uropathy. Pediatr Res 27: 103-107, 1990.
23. + channels in rabbit cortical collecting tubules by basolateral prostaglandin E2 is modulated by protein kinase C. J Clin Invest 90: 1328-1334, 1992.
24. Lorenz JN, Baird NR, Judd LM, Noonan WT, Andringa A, Doetschman T, Manning PA, Liu LH, Miller ML, Shull GE. Impaired renal NaCl absorption in mice lacking the ROMK potassium channel, a model for type II Bartter's syndrome. J Biol Chem 277: 37871-37880, 2002.
25. Lu M, Wang T, Yan Q, Wang W, Giebisch G, Hebert SC. ROMK is required for expression of the 70-pS K channel in the thick ascending limb. Am J Physiol Renal Physiol 286: F490-F495, 2004.
26. + channel (SK) activity in apical membranes of thick ascending limb and cortical collecting duct in ROMK (Bartter's) knockout mice. J Biol Chem 277: 37881-37887, 2002.
27. Neugarten J. Gender and the progression of renal disease. J Am Soc Nephrol 13: 2807-2809, 2002.
28. Nusing RM, Seyberth HW. The role of cyclooxygenases and prostanoid receptors in furosemide-like salt losing tubulopathy: the hyperprostaglandin E syndrome. Acta Physiol Scand 181: 523-528, 2004.
29. 2 mediates inhibition of rat thick ascending limb Cl reabsorption in chronic hypercalcemia. J Clin Invest 91: 2399-2407, 1993.
30. Proesmans W, Massa G, Vanderschueren-Lodeweyckx M. Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome. Pediatr Nephrol 2: 205-209, 1988.
31. Reinalter SC, Jeck N, Brochhausen C, Watzer B, Nusing RM, Seyberth HW, Komhoff M. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 62: 253-260, 2002.
32. Sabolic I, Asif AR, Budach WE, Wanke C, Bahn A, Burckhardt G. Gender differences in kidney function. Pflügers Arch 455: 397-429, 2007.
33. Schwalbe RA, Bianchi L, Accili EA, Brown AM. Functional consequences of ROMK mutants linked to antenatal Bartter's syndrome and implications for treatment. Hum Mol Genet 7: 975-980, 1998.
34. Schwartz D, DeSchryver-Kecskemeti K, Needleman P. Renal arachidonic acid metabolism and cellular changes in the rabbit renal vein constricted kidney: inflammation as a common process in renal injury models. Prostaglandins 27: 605-613, 1984.
35. Silbiger SR, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25: 515-533, 1995.
36. Simopoulos AP. Growth characteristics in patients with Bartter's syndrome. Nephron 23: 130-135, 1979.
37. Siragy HM, Carey RM. The Subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100: 264-269, 1997.
38. Sullivan JC, Sasser JM, Pollock DM, Pollock JS. Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. Hypertension 45: 406-411, 2005.
39. Takahashi N, Chernavvsky DR, Gomez RA, Igarashi P, Gitelman HJ, Smithies O. Uncompensated polyuria in a mouse model of Bartter's syndrome. Proc Natl Acad Sci USA 97: 5434-5439, 2000.
40. Vaisbich MH, Fujimura MD, Koch VH. Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol 19: 858-863, 2004.
41. Vollmer M, Koehrer M, Topaloglu R, Strahm B, Omran H, Hildebrandt F. Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome. Pediatr Nephrol 12: 69-71, 1998.
42. Wang T, Courtois-Coutry N, Giebisch G, Caplan MJ. A tyrosine-based signal regulates H-K-ATPase-mediated potassium reabsorption in the kidney. Am J Physiol Renal Physiol 275: F818-F826, 1998.
43. Wang T, Inglis FM, Kalb RG. Defective fluid and HCO(3)(-) absorption in proximal tubule of neuronal nitric oxide synthase-knockout mice. Am J Physiol Renal Physiol 279: F518-F524, 2000.
44. Wang T, Yang CL, Abbiati T, Schultheis PJ, Shull GE, Giebisch G, Aronson PS. Mechanism of proximal tubule bicarbonate absorption in NHE3 null mice. Am J Physiol Renal Physiol 277: F298-F302, 1999.
45. + channels: structure and function. Annu Rev Physiol 59: 413-436, 1997.
46. Wilcox CS, Welch WJ. Angiotensin II and thromboxane in the regulation of blood pressure and renal function. Kidney Int Suppl 30: S81-S83, 1990.